Trial intelligence / Profile preview

Qi Zhi Tong Luo Capsule in Vascular Cognitive Impairment

NCT04301466Phase 3Completed

Sponsor
Dongzhimen Hospital of Beijing University of Traditional Chinese Medicine
Start
Jul 2014
Primary completion
May 2018
Modality
Implantable Devices, Transdermal Patches, Inhalation Devices
Countries
1
01

Overview

A Phase 3 trial of Qizhi Tongluo in vascular cognitive impairment (VCI), sponsored by Dongzhimen Hospital of Beijing University of Traditional Chinese Medicine. Started Jul 2014; status: completed.

02

Drugs

Qizhi Tongluo
03

Conditions

vascular cognitive impairment (VCI)

Beyond the preview

Go deeper on NCT04301466.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04301466.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call